Allergan plc - FORM 8-K - EX-99.1

Attached files

file	filename
8-K - FORM 8-K - Allergan plc	d70120d8k.htm

Exhibit 99.1

The following tables represent the segment contribution of Allergan plc for the six months ended June 30, 2015, the three months ended June 30, 2015 and March 31, 2015, the year ended December 31, 2014 and the three months ended December 31, 2014, September 30, 2014, June 30, 2014 and March 31, 2014 ($ in millions):


	Six Months Ended June 30, 2015
	US			US Medical			International			Global			Anda
	Brands			Aesthetics			Brands			Generics			Distribution			Total
Net revenues	$	4,234.1		$	566.6		$	947.5		$	3,260.8		$	924.0		$	9,933.0

Operating expenses:
Cost of sales⁽¹⁾		533.9			39.0			244.3			1,321.7			808.5			2,947.4
Selling and marketing		831.7			111.6			249.6			296.5			62.7			1,552.1
General and administrative		105.7			13.9			70.1			177.2			18.0			384.9

Segment Contribution	$	2,762.8		$	402.1		$	383.5		$	1,465.4		$	34.8		$	5,048.6

Contribution margin		*65.3*	%		*71.0*	%		*40.5*	%		*44.9*	%		*3.8*	%		*50.8*	%

	Three Months Ended June 30, 2015
	US			US Medical			International			Global			Anda
	Brands			Aesthetics			Brands			Generics			Distribution			Total
Net revenues	$	2,435.7		$	486.8		$	717.0		$	1,629.0		$	462.4		$	5,730.9

Operating expenses:
Cost of sales⁽¹⁾		307.3			34.0			159.5			680.3			404.5			1,585.6
Selling and marketing		459.4			97.9			181.8			162.1			31.3			932.5
General and administrative		47.2			11.2			47.5			82.2			8.9			197.0

Segment Contribution	$	1,621.8		$	343.7		$	328.2		$	704.4		$	17.7		$	3,015.8

Contribution margin		*66.6*	%		*70.6*	%		*45.8*	%		*43.2*	%		*3.8*	%		*52.6*	%

	Three Months Ended March 31, 2015
	US			US Medical			International			Global			Anda
	Brands			Aesthetics			Brands			Generics			Distribution			Total
Net revenues	$	1,798.4		$	79.8		$	230.5		$	1,631.8		$	461.6		$	4,202.1

Operating expenses:
Cost of sales⁽¹⁾		226.6			5.0			84.8			641.4			404.0			1,361.8
Selling and marketing		372.3			13.7			67.8			134.4			31.4			619.6
General and administrative		58.5			2.7			22.6			95.0			9.1			187.9

Segment Contribution	$	1,141.0		$	58.4		$	55.3		$	761.0		$	17.1		$	2,032.8

Contribution margin		*63.4*	%		*73.2*	%		*24.0*	%		*46.6*	%		*3.7*	%		*48.4*	%


	Year Ended December 31, 2014
	US			US Medical		International			Global			Anda
	Brands			Aesthetics		Brands			Generics			Distribution			Total
Net revenues	$	4,502.8		$	—	$	698.7		$	5,961.6		$	1,683.7		$	12,846.8

Operating expenses:
Cost of sales⁽¹⁾		723.6			—		328.4			2,547.9			1,456.2			5,056.1
Selling and marketing		804.6			—		155.0			527.2			112.6			1,599.4
General and administrative		192.6			—		67.2			384.6			36.4			680.8

Segment Contribution	$	2,782.0		$	—	$	148.1		$	2,501.9		$	78.5		$	5,510.5

Contribution margin		*61.8*	%				*21.2*	%		*42.0*	%		*4.7*	%		*42.9*	%

	Three Months Ended December 31, 2014
	US			US Medical		International			Global			Anda
	Brands			Aesthetics		Brands			Generics			Distribution			Total
Net revenues	$	1,785.9		$	—	$	185.8		$	1,599.7		$	443.3		$	4,014.7

Operating expenses:
Cost of sales⁽¹⁾		343.2			—		85.2			676.5			385.7			1,490.6
Selling and marketing		339.7			—		43.6			140.0			29.6			552.9
General and administrative		68.1			—		20.0			75.5			10.7			174.3

Segment Contribution	$	1,034.9		$	—	$	37.0		$	707.7		$	17.3		$	1,796.9

Contribution margin		*57.9*	%				*19.9*	%		*44.2*	%		*3.9*	%		*44.8*	%

	Three Months Ended September 30, 2014
	US			US Medical		International			Global			Anda
	Brands			Aesthetics		Brands			Generics			Distribution			Total
Net revenues	$	1,577.5		$	—	$	199.4		$	1,453.6		$	423.2		$	3,653.7

Operating expenses:
Cost of sales⁽¹⁾		241.8			—		97.5			632.5			364.8			1,336.6
Selling and marketing		314.6			—		41.3			131.7			28.9			516.5
General and administrative		74.6			—		18.5			101.5			9.1			203.7

Segment Contribution	$	946.5		$	—	$	42.1		$	587.9		$	20.4		$	1,596.9

Contribution margin		*60.0*	%				*21.1*	%		*40.4*	%		*4.8*	%		*43.7*	%


	Three Months Ended June 30, 2014
	US			US Medical		International			Global			Anda
	Brands			Aesthetics		Brands			Generics			Distribution			Total
Net revenues	$	564.6		$	—	$	169.1		$	1,474.6		$	427.0		$	2,635.3

Operating expenses:
Cost of sales⁽¹⁾		71.1			—		74.3			631.2			374.5			1,151.1
Selling and marketing		75.7			—		36.4			136.6			27.1			275.8
General and administrative		24.7			—		13.2			97.0			8.8			143.7

Segment Contribution	$	393.1		$	—	$	45.2		$	609.8		$	16.6		$	1,064.7

Contribution margin		*69.6*	%				*26.7*	%		*41.4*	%		*3.9*	%		*40.4*	%

	Three Months Ended March 31, 2014
	US			US Medical		International			Global			Anda
	Brands			Aesthetics		Brands			Generics			Distribution			Total
Net revenues	$	574.8		$	—	$	144.4		$	1,433.7		$	390.2		$	2,543.1

Operating expenses:
Cost of sales⁽¹⁾		67.5			—		71.4			607.7			331.2			1,077.8
Selling and marketing		74.6			—		33.7			118.9			27.0			254.2
General and administrative		25.2			—		15.5			110.6			7.8			159.1

Segment Contribution	$	407.5		$	—	$	23.8		$	596.5		$	24.2		$	1,052.0

Contribution margin		*70.9*	%				*16.5*	%		*41.6*	%		*6.2*	%		*41.4*	%

(1)	Excludes amortization and impairment of acquired intangibles including product rights.

Allergan plc - FORM 8-K - EX-99.1 - August 6, 2015

Attached files

Allergan plc Reports